(Q46394444)

English

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Leishmania infantum

1 reference

based on heuristic

inferred from title

author name string

Jean-Loup Lemesre

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Philippe Holzmuller

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Mireille Cavaleyra

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Rachel Bras Gonçalves

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Grégory Hottin

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Gérard Papierok

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

23

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

22

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

2825-2840

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Immunology of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

The immune response to Leishmania: mechanisms of parasite control and evasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Regulation of protective immunity against Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

TH1 and TH2 cell antigen receptors in experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Epidermal immunocompetence in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Vaccines against leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Follow-up study of a vaccination programme against cutaneous leishmaniasis. I. Vaccination with a 5 year-old human strain of L. tropica from the Negev

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Canine leishmaniasis: epidemiological risk and the experimental model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Visceral leishmaniasis in Teresina, State of Piauí, Brazil: preliminary observations on the detection and transmissibility of canine and sandfly infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

TheLeishmaniapromastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity toL. major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Interferon-gamma and interleukin-4 in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

based on heuristic

inferred from DOI database lookup

Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.061

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.11.061

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15780731

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46394444&oldid=2109251295"